U.S. Rare Earth Minerals, Inc. Announces $600,000 Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
U.S. Rare Earth Minerals, Inc. Announces $600,000 Annual EXCELERITE(R) Sales to India by Bio Multimin, Inc.

LAS VEGAS, Oct. 28, 2013 (GLOBE NEWSWIRE) -- U.S. Rare Earth Minerals, Inc.'s, (OTCQB:USMN) announced today that its former subsidiary, Bio Multimin, Inc. (Bio) has commenced placing pre-paid orders, for immediate delivery of bulk EXCELERITE® to its India distributor amounting to $50,000 per month. A minimum of two containers per week will be shipped through calendar 2014.

Michael Herod, CEO and President of Bio stated, "It has taken many months to finalize an agreement for this bulk EXCELERITE® sale and I am pleased to announce its successful conclusion. I am confident that this revenue stream will be permanent and continue to grow over the months and years to come. The shareholders of Bio Multimin, Inc. and USMN both benefit from this established India distributor's ongoing success with our EXCELERITE® products."

From Vietnam, CEO and President of USMN, Dennis Cullison, congratulated Mr. Herod for finalizing this important sale. Mr. Cullison commented, "Thanks to your hard work, you have not only ensured the success of Bio Multimin but that of USMN as well. With our Vietnam sales and now India, we are looking forward to a long and prosperous future for both companies." 

U.S. Rare Earth Minerals, Inc.

U.S. Rare Earth Minerals, Inc. (USMN), is engaged in the sales and distribution of products derived from the Company's mining activities in Nevada relating to certain natural mineral deposits and other natural rare earth minerals. Products of USMN consist of natural minerals for animal consumption as well as agricultural products sold under the brand name EXCELERITE®. Customers of USMN include some of the world's most widely recognized companies that have well known consumer brands. USMN is headquartered in Las Vegas, Nevada. The company maintains a web site at: www.us-rem.com .

This press release contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of U.S. Rare Earth Minerals, Inc., and members of management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those contemplated by such forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

USMN Contact Information Corporate Management Inquiries: Production & Sales: Press & Media:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation of Stock Transactions: TASK, VBTX, TURN Insights

Updated Category News Views 125

Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...

Continue Reading
Comprehensive Analysis of NVIDIA in the Semiconductor Market

Updated Category News Views 678

Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...

Continue Reading
Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event

Updated Category News Views 54

Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...

Continue Reading
The Rising Stars: Growth Potential of Key Investments

Updated Category News Views 95

Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...

Continue Reading
PharmAla Partners with Logistics Expert for Clinical Trials

Updated Category News Views 114

PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...

Continue Reading